Should We Monitor Glucose and Biomarkers in Diabetics over Heart Surgery?

Should We Monitor Glucose and Biomarkers in Diabetics over Heart Surgery?

Hyperglycemia is associated with adverse outcomes after coronary artery bypass grafting (CABG). While there is a consensus that blood glucose control may benefit patients undergoing CABG, the role of biomarkers, optimal method, and duration of such monitoring are still unclear. The aim of this study...

Full description

Bibliographic Details
Main Authors: Elena Z. Golukhova, Ljubov S. Lifanova, Yaroslava V. Pugovkina, Marina V. Grigoryan, Naida I. Bulaeva
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
diabetes mellitus
insulin
glucose monitoring
coronary bypass surgery
outcomes
Online Access:https://www.mdpi.com/2077-0383/10/15/3399

Similar Items

Similar Items